Nonvaricose upper gastrointestinal bleeding
Conditions
Interventions
Sponsors
Guangdong Provincial People's Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Hospitalized cases; (2) There is no limitation on gender or age; (3) Use of Ilaprazole Sodium for Injection or Esomeprazole Sodium for Injection for more than 2 days (=3 days).
Exclusion criteria
Exclusion criteria: (1) Hospitalized patients who used other PPI or H2 receptor antagonists (omeprazole, Lansoprazole, pantoprazole, rabeprazole, cimetidine, ranitidine, Famotidine, nizatidine, Roxatidine, ebromotidine, and miphentidine) in combination; (2) Patients who used Ilaprazole Sodium for Injection and Esomeprazole Sodium for Injection; (3) Deaths not caused by gastrointestinal bleeding; (4) Clinically confirmed cases of upper digestive tract tumor; (5) Clinically confirmed cases of varicose upper gastrointestinal bleeding; (6) Clinically confirmed cases of lower gastrointestinal bleeding.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevention success rate;Hemostatic effective rate;Adverse reaction; | — |
Countries
China
Contacts
Public ContactWeihua Lai
Guangdong Provincial People's Hospital
Outcome results
None listed